1. Home
  2. CATO vs TCRX Comparison

CATO vs TCRX Comparison

Compare CATO & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cato Corporation (The)

CATO

Cato Corporation (The)

HOLD

Current Price

$3.33

Market Cap

58.0M

ML Signal

HOLD

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

HOLD

Current Price

$0.90

Market Cap

67.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CATO
TCRX
Founded
1946
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.0M
67.3M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
CATO
TCRX
Price
$3.33
$0.90
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.00
AVG Volume (30 Days)
56.9K
988.5K
Earning Date
05-21-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
68.04
12.28
EPS
0.47
N/A
Revenue
$653,812,000.00
$10,325,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$19.81
P/E Ratio
$6.77
N/A
Revenue Growth
0.62
266.65
52 Week Low
$2.59
$0.83
52 Week High
$4.92
$2.57

Technical Indicators

Market Signals
Indicator
CATO
TCRX
Relative Strength Index (RSI) 54.15 42.89
Support Level $2.85 N/A
Resistance Level $3.62 $1.21
Average True Range (ATR) 0.23 0.11
MACD -0.01 -0.01
Stochastic Oscillator 56.62 13.55

Price Performance

Historical Comparison
CATO
TCRX

About CATO Cato Corporation (The)

The Cato Corp seeks to offer quality fashion apparel and accessories at low prices every day, in junior/missy and plus sizes. The Cato concept's stores and e-commerce website feature a broad assortment of apparel and accessories, including dressy, career, and casual sportswear, dresses, coats, shoes, lingerie, costume jewelry, and handbags. Management believes the Company's success is dependent upon its ability to differentiate its stores from department stores, mass merchandise discount stores, and competing specialty stores. The key elements of the Company's business are: Merchandise Assortment, Value Pricing, Strip Shopping Center Location, Customer Service, Credit and Layaway Programs.

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Share on Social Networks: